Abstract 1465: Histone deacetylase inhibitor suberoylanilide hydroxamic acid blocks epithelial-mesenchymal transition exhibited by Tera-2 embryonal carcinoma cells with a stem cell phenotype

Hydroxamic Acid ◽

Embryonal Carcinoma ◽

Epithelial Mesenchymal Transition ◽

Carcinoma Cells ◽

Cell Phenotype ◽

Embryonal Carcinoma Cells ◽

Mesenchymal Transition ◽

Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability

BMC Cancer ◽

10.1186/s12885-019-5482-y ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 1

Author(s):

Zhihua Shen ◽

Xiaomin Liao ◽

Zhongming Shao ◽

Muyin Feng ◽

Jianling Yuan ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Cell Invasion ◽

Histone Deacetylase Inhibitor Trichostatin

Epithelial Mesenchymal Transition ◽

Trichostatin A ◽

Carcinoma Cells ◽

Short Term ◽

Mesenchymal Transition ◽

Deacetylase Inhibitor ◽

Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid

International Journal of Oncology ◽

10.3892/ijo.30.5.1181 ◽

2007 ◽

Cited By ~ 4

Author(s):

Hidemi Rikiishi ◽

Fumiaki Shinohara ◽

Tomonori Sato ◽

Yoshitaro Sato ◽

Maiko Suzuki ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Oral Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Histone Deacetylase ◽

Squamous Cell ◽

Hydroxamic Acid ◽

Carcinoma Cells ◽

A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.94.21.11295 ◽

1997 ◽

Vol 94 (21) ◽

pp. 11295-11300 ◽

Cited By ~ 77

Author(s):

S. Minucci ◽

V. Horn ◽

N. Bhattacharyya ◽

V. Russanova ◽

V. V. Ogryzko ◽

...

Keyword(s):

Histone Deacetylase ◽

Embryonal Carcinoma ◽

Carcinoma Cells ◽

Embryonal Carcinoma Cells ◽

Retinoid Receptor ◽

Deacetylase Inhibitor ◽

Receptor Action

Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment

Cancer Biology & Therapy ◽

10.4161/cbt.3.11.1190 ◽

2004 ◽

Vol 3 (11) ◽

pp. 1109-1120 ◽

Cited By ~ 29

Author(s):

Niquiche Sangster-Guity ◽

Li-Ming Yu ◽

Paulette McCormick

Keyword(s):

Retinoic Acid ◽

Histone Deacetylase ◽

Embryonal Carcinoma ◽

Molecular Profiling ◽

Carcinoma Cells ◽

Embryonal Carcinoma Cells ◽

Deacetylase Inhibitor ◽

Inhibitor Treatment

The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation

European Journal of Cancer ◽

10.1016/j.ejca.2009.06.024 ◽

2009 ◽

Vol 45 (13) ◽

pp. 2425-2438 ◽

Cited By ~ 61

Author(s):

Daniela Carlisi ◽

Marianna Lauricella ◽

Antonella D’Anneo ◽

Sonia Emanuele ◽

Liliana Angileri ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Carcinoma Cells ◽

Human Hepatocellular Carcinoma Cells

Hepatocellular Carcinoma Cells ◽

Deacetylase Inhibitor ◽

Induced Apoptosis ◽

Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-04-0344 ◽

2007 ◽

Vol 6 (11) ◽

pp. 2967-2975 ◽

Cited By ~ 52

Author(s):

Ann M. Gillenwater ◽

Meiling Zhong ◽

Reuben Lotan

Keyword(s):

Head And Neck ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Squamous Carcinoma ◽

Carcinoma Cells ◽

Squamous Carcinoma Cells ◽

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells

International Journal of Cancer ◽

10.1002/ijc.22558 ◽

2007 ◽

Vol 121 (3) ◽

pp. 656-665 ◽

Cited By ~ 123

Author(s):

Takashi Kumagai ◽

Naoki Wakimoto ◽

Dong Yin ◽

Sigal Gery ◽

Norihiko Kawamata ◽

...

Keyword(s):

Pancreatic Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Human Pancreatic Cancer ◽

Pancreatic Cancer Cells ◽

Treatment of canine haemangiosarcoma with suberoylanilide hydroxamic acid, a histone deacetylase inhibitor

Veterinary and Comparative Oncology ◽

10.1111/j.1476-5810.2004.00057.x ◽

2004 ◽

Vol 2 (4) ◽

pp. 243-248 ◽

Cited By ~ 12

Author(s):

L. A. Cohen ◽

B. Powers ◽

S. Amin ◽

D. Desai

Keyword(s):

Histone Deacetylase ◽

Hydroxamic Acid ◽

The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Confers Acute Neuroprotection After Intracerebral Hemorrhage in Mice

Translational Stroke Research ◽

10.1007/s12975-015-0421-y ◽

2015 ◽

Vol 7 (2) ◽

pp. 141-148 ◽

Cited By ~ 32

Author(s):

Sangeetha Sukumari-Ramesh ◽

Cargill H. Alleyne ◽

Krishnan M. Dhandapani

Keyword(s):

Intracerebral Hemorrhage ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Suberoylanilide Hydroxamic Acid, a Histone Deacetylase Inhibitor, Induces the Production of Anti-inflammatory Cyclodepsipeptides from Beauveria felina

Journal of Natural Products ◽

10.1021/np400143j ◽

2013 ◽

Vol 76 (7) ◽

pp. 1260-1266 ◽

Cited By ~ 29

Author(s):

Yu-Ming Chung ◽

Mohamed El-Shazly ◽

Da-Wei Chuang ◽

Tsong-Long Hwang ◽

Teigo Asai ◽

...

Keyword(s):

Histone Deacetylase ◽

Hydroxamic Acid ◽

Deacetylase Inhibitor ◽

Anti Inflammatory